GREEN CROSS WellBeing Corporation

KOSDAQ:A234690 주식 보고서

시가총액: ₩195.1b

GREEN CROSS WellBeing 미래 성장

Future 기준 확인 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for GREEN CROSS WellBeing.

주요 정보

n/a

수익 성장률

n/a

EPS 성장률

Personal Products 수익 성장11.8%
매출 성장률n/a
향후 자기자본 수익률n/a
애널리스트 커버리지

None

마지막 업데이트n/a

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Investors Appear Satisfied With GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) Prospects As Shares Rocket 32%

Sep 20
Investors Appear Satisfied With GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) Prospects As Shares Rocket 32%

GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) P/E Still Appears To Be Reasonable

Jul 25
GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) P/E Still Appears To Be Reasonable

Is GREEN CROSS WellBeing (KOSDAQ:234690) Using Too Much Debt?

Jul 01
Is GREEN CROSS WellBeing (KOSDAQ:234690) Using Too Much Debt?

Subdued Growth No Barrier To GREEN CROSS WellBeing Corporation (KOSDAQ:234690) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To GREEN CROSS WellBeing Corporation (KOSDAQ:234690) With Shares Advancing 28%

The Return Trends At GREEN CROSS WellBeing (KOSDAQ:234690) Look Promising

Feb 26
The Return Trends At GREEN CROSS WellBeing (KOSDAQ:234690) Look Promising

Returns On Capital At GREEN CROSS WellBeing (KOSDAQ:234690) Paint A Concerning Picture

Mar 30
Returns On Capital At GREEN CROSS WellBeing (KOSDAQ:234690) Paint A Concerning Picture

Is GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) Shareholder Ownership Skewed Towards Insiders?

Mar 02
Is GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) Shareholder Ownership Skewed Towards Insiders?

Introducing GREEN CROSS WellBeing (KOSDAQ:234690), A Stock That Climbed 44% In The Last Year

Feb 02
Introducing GREEN CROSS WellBeing (KOSDAQ:234690), A Stock That Climbed 44% In The Last Year

Is GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) 4.4% ROE Better Than Average?

Jan 03
Is GREEN CROSS WellBeing Corporation's (KOSDAQ:234690) 4.4% ROE Better Than Average?

Has GREEN CROSS WellBeing (KOSDAQ:234690) Got What It Takes To Become A Multi-Bagger?

Dec 08
Has GREEN CROSS WellBeing (KOSDAQ:234690) Got What It Takes To Become A Multi-Bagger?

이 섹션에서는 일반적으로 투자자가 회사의 수익 창출 능력을 이해하는 데 도움이 되도록 전문 애널리스트의 컨센서스 추정치를 기반으로 수익 및 수익 성장 전망치를 제시합니다. 하지만 GREEN CROSS WellBeing 은 충분한 과거 데이터를 제공하지 않았고 애널리스트 예측도 없기 때문에 과거 데이터를 추정하거나 애널리스트 예측을 사용하여 미래 수익을 안정적으로 계산할 수 없습니다.

SimplyWall St에서 다루는 기업의 97%가 과거 재무 데이터를 가지고 있기 때문에 이는 매우 드문 상황입니다.

수익 및 매출 성장 예측

KOSDAQ:A234690 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
3/31/2024126,4436,7073421,694N/A
12/31/2023120,5356,748-2,884-1,030N/A
9/30/2023117,5377,086-2,4501,336N/A
6/30/2023116,0728,145-3,2202,020N/A
3/31/2023112,3648,361-3,7804,201N/A
12/31/2022109,7298,001-7,5851,824N/A
9/30/2022103,9957,072-4,3055,544N/A
6/30/202297,6146,679-14,4693,845N/A
3/31/202294,1506,876-20,2208,059N/A
12/31/202190,9686,703-34,6148,684N/A
9/30/202186,6784,544-43,1134,278N/A
6/30/202187,1412,801-40,6382,349N/A
3/31/202181,4931,824-37,233-2,747N/A
12/31/202075,6031,529-28,550-6,193N/A
9/30/202072,8843,733-15,701-1,636N/A
6/30/202067,0313,905-11,797-2,678N/A
3/31/202066,9384,253-6,711-468N/A
12/31/201966,9385,6993,5755,415N/A
9/30/201962,1455,7401,3612,985N/A
6/30/201959,4214,9374,2565,398N/A
3/31/201955,7075,3224,1035,103N/A
12/31/201853,8835,6784,8005,446N/A
12/31/201745,0714,106N/A4,105N/A
12/31/201636,6513,597N/A-1,562N/A
12/31/20157,875512N/A747N/A

애널리스트 미래 성장 예측

수입 대 저축률: Insufficient data to determine if A234690's forecast earnings growth is above the savings rate (2.6%).

수익 vs 시장: Insufficient data to determine if A234690's earnings are forecast to grow faster than the KR market

고성장 수익: Insufficient data to determine if A234690's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: Insufficient data to determine if A234690's revenue is forecast to grow faster than the KR market.

고성장 수익: Insufficient data to determine if A234690's revenue is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if A234690's Return on Equity is forecast to be high in 3 years time


성장 기업 발견